Home » Covid Italy, bulletin of 18 July 2022: positive cases and deaths

Covid Italy, bulletin of 18 July 2022: positive cases and deaths

by admin
Covid Italy, bulletin of 18 July 2022: positive cases and deaths

In the last 24 hours in Italy, 31,204 new cases of coronavirus have been recorded. The epidemic curve in Italy is confirmed in decline, after having probably crossed the peak last week. Yesterday the infections were 67,817, last Monday they were 37,756.

The swabs carried out are 135,642 (yesterday 297,754) with a positivity rate that rises slightly from 22.8% to 23%.

There have been 112 deaths in the last 24 hours (yesterday 79) for a total of 170,037 victims since the beginning of the pandemic.

Intensive care is on the rise, 14 more (yesterday -2): in all there are 417 with 41 admissions that day. The number of ordinary hospitalizations also continues to grow: there are 272 more (yesterday +142) for a total of 10,848. This is what emerges from the daily bulletin of the Ministry of Health.

The region with the most Covid cases today is Emilia Romagna with 4,175 infections, followed by Lazio (+3.708), Lombardy (+3.262), Campania (+3.060) and Sicily (+2.678). The total cases since the beginning of the pandemic are 20,177,910. The discharged / healed in the last 24 hours are 42,594 (yesterday +52,417) for a total that rises to 18,553,478. The currently positive ones drop by 10,655 units (yesterday +16,500) and are 1,454,395 in all, of which 1,443,130 in home isolation.

Ema starts evaluation of Pfizer vaccine for children 6 months-4 years

The EMA has begun to evaluate the request to extend the use of the Covid 19 Comirnaty vaccine (Pfizer-Biontech, ed), in children from 6 months to 4 years. This was announced by the European Medicines Agency itself via twitter.

See also  The strong typhoon "Xuanlannuo" has affected the peripheral circulation from today, and the Hangzhou Provincial Defense Index has upgraded the emergency response to typhoon prevention to level III! -Hangzhou News Center-Hangzhou Net

Covid, the Capodimonte hub reopens in Naples: a hundred in a row


Agenas: in 7 regions over 20% of Covid departments occupied

The percentage of places in non-critical area wards occupied by Covid patients is stable at 16% over 24 hours in Italy. But in 7 regions it exceeds 20%: these are Umbria (42%), Calabria (32%), Sicily (28%), Basilicata (27%), Liguria (25%), Valle d’Aosta (24%) and Friuli Venezia Giulia (21%). On the other hand, the percentage of intensive care units occupied by Covid patients is stable at 4% in Italy. Data from the National Agency for Regional Health Services (Agenas) refer to July 13, but were released today.

Ecdc: cases and deaths in Europe will increase

Although death rates from Covid in Europe “have remained stable over the past five weeks”, epidemiological models from the European Center for Disease Prevention and Control “indicate that both case notification rates and death rates will increase” . The ECDC writes in a note accompanying the “Preliminary public health considerations for Covid-19 vaccination strategies in the second half of 2022″. In view of the autumn, the ECDC indicates the urgent need to establish solid and integrated surveillance systems on the pandemic and respiratory viruses in general.

Ecdc: vaccinating over 60s now with a second booster

The European Center for Disease Prevention and Control has reiterated the urgency to vaccinate the over 60 and vulnerable with a second booster dose of the anti-Covid vaccine against the spread of BA.4 and BA.5 variants. A possibility to which Italy has already opened and on which the Ministry of Health has launched an awareness campaign.

“People over the age of 60 and with underlying comorbidities remain at greater risk of serious illness – writes the ECDC in a note -. The mathematical models suggest clear advantages of a first launch of a second booster to protect older people. above 60 years. Therefore, early introduction of the second booster should be considered not only for the population aged 80 and over, but also for adults aged 60 to 79 and individuals with previous pathologies regardless of age to prevent serious diseases and safeguard the health system capacity “.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy